Mutations of human PHF8 cluster within its JmjC encoding exons and are linked to mental retardation (MR) and a cleft lip/palate phenotype. Sequence comparisons, employing structural insights, suggest that PHF8 contains the double stranded b-helix fold and ferrous iron binding residues that are present in 2-oxoglutarate-dependent oxygenases. We report that recombinant PHF8 is an Fe(II) and 2-oxoglutarate-dependent N 1 -methyl lysine demethylase, which acts on histone substrates. PHF8 is selective in vitro for N 1 -di-and mono-methylated lysine residues and does not accept trimethyl substrates. Clinically observed mutations to the PHF8 gene cluster in exons encoding for the double stranded b-helix fold and will therefore disrupt catalytic activity. The PHF8 missense mutation c.836C>T is associated with mild MR, mild dysmorphic features, and either unilateral or bilateral cleft lip and cleft palate in two male siblings. This mutant encodes a F279S variant of PHF8 that modifies a conserved hydrophobic region; assays with both peptides and intact histones reveal this variant to be catalytically inactive. The dependence of PHF8 activity on oxygen availability is interesting because the occurrence of fetal cleft lip has been demonstrated to increase with maternal hypoxia in mouse studies. Cleft lip and other congenital anomalies are also linked indirectly to maternal hypoxia in humans, including from maternal smoking and maternal anti-hypertensive treatment. Our results will enable further studies aimed at defining the molecular links between developmental changes in histone methylation status, congenital disorders and MR.
INTRODUCTION
Mutations to the human PHF8 gene are associated with Siderius X-linked mental retardation (XLMR) syndrome (OMIM 300263). The symptoms of Siderius XLMR syndrome include, in addition to mild MR, facial dysmorphism and cleft lip/palate, implying a role for PHF8 (JHDM1F) in midline formation and cognitive functions (1, 2) . The prevalence of cleft lip with or without cleft palate is among the most common of all birth defects, averaging at 10.5 per 10 000 live births in the USA; the estimated lifetime costs of treating children born with this disorder each year are $700 million (3) . Recently, a microdeletion encompassing all of the PHF8 and FAM120C genes and parts of WNK3 was reported in two brothers with autism spectrum disorders, causing hypertelorism and broad halluces in addition to the Siderius XLMR syndrome features (4) . Episodes of maternal respiratory hypoxia in mice also correlate with increased incidence of cleft lip/palate (gestational day 10-11, 10% O 2 ), whereas hyperoxia rescued mouse strains that are genetically † These authors contributed equally to this work. ‡ These authors contributed equally to this work.
Ã
To whom correspondence should be addressed. PHF8 is predicted to be one of a sequence-related group of human proteins, the PHF subfamily, which also includes JHDM1D and PHF2 (JHDM1E), the function(s) of which have not been identified. Predicted amino acid sequence analyses imply that the PHF proteins are part of the JmjC subfamily of human Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenases (6) that also depend on cellular oxygen levels for catalytic activity, some of which are histone lysine demethylases. All of the studied 2OG-dependent demethylases appear to be sequence-specific (6) . All four types of identified mutations/deletions to PHF8 cluster in the exons encoding for the predicted JmjC (or double-stranded b-helix) domain, which is common to all identified 2OG oxygenases (2,6 -8) .
Post-translational modifications to histones are important in epigenetic regulation, and the enzymes responsible for their placement and removal are currently the focus of intense research. Several JmjC domain containing histone demethylases have been implicated in diseases including prostate cancer (the JMJD2 family of histone H3K9/36 demethylases) (9) and XLMR (JARID1C, a histone H3K4 demethylase) (10 -13). Here we report that PHF8 is an iron and 2OG-dependent demethylase specific for di-and mono-N 1 -methylated lysine residues; compared with other studied 2OG-dependent demethylases, the PHF8 catalytic domain appears in vitro to have relatively lax sequence selectivity.
RESULTS

Identification of PHF8 as a 2OG oxygenase by activity assays
To investigate whether, as predicted, PHF8 is a 2OG oxygenase, we prepared recombinant forms of full-length PHF8, as well as N-and C-terminal deletions of PHF8; PHF8 1 -447 and PHF8 79 -447 were purified to near homogeneity. Because many 2OG oxygenases can oxidize 2OG in the absence of their 'prime' substrate, we then employed an assay for PHF8 measuring the turnover of 1-[ 14 C]-2OG to succinate and [ 14 C]-CO 2 . We observed PHF8-dependent stimulation of 2OG turnover that was inhibited by lack of Fe(II), as well as by pyridine-2,4-dicarboxylate (2,4-PDCA), a known 2OG oxygenase inhibitor (Fig. 1A) . Mutation of a predicted Fe(II) binding residue (H247A) ablated activity (Supplementary Material, Fig. S1 ). These results reveal that PHF8 is a 2OG-dependent oxygenase. 
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In an effort to identify a substrate for PHF8, we then screened a set of peptides corresponding to fragments of potential target proteins, including N 1 -lysine tri-and dimethylated histone fragments, for stimulation of 2OG turnover by PHF8. Increased 2OG turnover was only observed for dimethylated lysine-9 of histone 3 (H3K9me2; analogous abbreviations are used throughout) and H3K36me2 peptides. Notably, H3K9me3 did not show stimulation of 2OG turnover above control levels (Fig. 1A) , suggesting that dimethylated lysine residues are substrates of PHF8.
Investigating PHF8 substrate selectivity by mass spectrometric based screening
We then investigated the sequence selectivity of PHF8 by mass spectrometry using peptide fragments of H3 and H4 histones containing methylated lysine residues. The catalytic domain of PHF8 catalyzed demethylation of H3K9me2/me1, H3K27me2 and H3K36me2, but not of H4K20 peptides (Supplementary Material, Fig. S1 ). Under current assay conditions, we did not observe demethylation of H3K36me1, but observed demethylation of H3K36me2 to give both H3K36me1 and some H3K36me0. It is possible that this reflects incomplete release of the H3K36me1 derived from H3K36me2 during catalysis to H3K36me0. These results suggest that the PHF8 catalytic domain may have an unusually broad sequence selectivity, at least in vitro, compared with other JmjC histone demethylases (e.g. FBXL11 is reported to be selective for H3K36) (14) . Interestingly, both the 2OG oxygenases factor inhibiting HIF (FIH) and JMJD6, which although hydroxylases are sequence-related to the JmjC demethylases, have broad substrate selectivity (15 -19) , with FIH being shown to have large numbers of substrates in vitro and in vivo. We thus do not exclude the possibility of non-histone substrates for PHF8.
Because some JmjC domain containing 2OG oxygenases function as hydroxylases, rather than demethylases, we tested substrates of FIH [asparaginyl hydroxylation of hypoxia-inducible transcription factor (HIFa) and ankyrins] (17, 20) and JMJD6 (lysyl hydroxylation of splicing-related proteins) (18) as PHF8 substrates; however, no hydroxylase activity was observed (Supplementary Material, Fig. S2 ).
PHF8 removes methylation marks on calf histones
Because the selectivity of 2OG oxygenases observed with peptide fragments does not always reflect their selectivity with regards to proteins (18), we then carried out assays with intact calf histones as substrates (Fig. 1B) , using the known histone demethylase JMJD2A for comparison. As reported (21), JMJD2A reduced H3K9me3 and H3K36me3/ me2/me1 methylation levels. PHF8-mediated demethylation was observed for H3K9me2, H3K9me1, H3K36me2 as well as for H3K27me2 (Fig. 1E) . In contrast to JMJD2A, with PHF8 demethylation was neither observed for trimethylated H3K9, nor for H3K36, nor for any of the investigated H3K4 and H3K79 methylation states. Consistent with the mass spectrometric assays, H3K36me1 was also not found to be a substrate for PHF8.
Structural predictions for PHF8 based on deposited coordinates for FBXL11 (22) and structures of JMJD2A (21) indicate that the methyl lysine binding pocket for PHF8 is similar to that of FBXL11, which is also selective for di-and mono-methyl lysine residues (14) , and smaller than the methyllysine binding pocket of JMJD2A, which is selective for di-and trimethyl lysine residues (Fig. 1C and D) (21) .
The methylation state selectivity of PHF8 was also confirmed by side-by-side analysis of mono-, di-and tri-methylated H3K9 peptides with PHF8 and JMJD2A in vitro using mass spectrometry (Supplementary Material, Fig. S5 ): PHF8 was selective for di-and mono-methylated forms, whereas JMJD2A was selective for tri-and di-methylated forms.
Clinically observed PHF8 mutants associated with cleft lip abrogate PHF8 activity
We then investigated whether clinically observed PHF8 mutations associated with Siderius XLMR syndrome affect PHF8 catalysis (Fig. 2A) . Analysis of a structural model for PHF8, based on the reported crystallographic data for JMJD2A (21) and FBXL11 (22) , reveals that three of the four identified types of PHF8 mutations will lead to major modifications to the double-stranded b-helix/JmjC domain (2, 7, 8) , almost certainly causing loss of function (Fig. 2B  and Supplementary Material, Fig. S6 for detailed analyses) . However, one point mutation, F279S (8), replaces a hydrophobic phenylalanine with a more polar serine residue, within a hydrophobic pocket close to the active site and which is apparently conserved in all members of the FBXL/ PHF subfamily (Supplementary Material, Fig. S6 ). The functional effect of the PHF8 F279S mutation was unclear from the structural model. In affected individuals, this mutation caused symptoms including mild MR, dysmorphic features and either unilateral or bilateral cleft lip/palate. Notably, PHF8 79 -447 F279S was prepared and found to be completely catalytically inactive, both by 2OG turnover and mass spectrometric assays (Fig. 2D and Supplementary Material, Fig. S6 ). Similarly, when using calf histones as substrates, both H3K9me2 and H3K36me2 levels were reduced with wild-type PHF8 79 -447 , but neither by the F279S nor by the H247A variants, even when using a 10-fold increase in PHF8 79 -447 F279S levels (Fig. 2C) .
To investigate the effect of the F279S variation on cellular localization of PHF8, we transfected HeLa cells with human full-length PHF8 bearing an N-terminal HA epitope tag (HA-PHF8). The HA-PHF8 overexpressing cells were fixed after 24 h; immunofluorescence assays demonstrated that wild-type PHF8 localizes to the nucleus, consistent with its function as a histone demethylase (Fig. 2E ). Significant changes in global methylation levels were not observed under these conditions (data not shown), suggesting that PHF8 is either specifically targeted to certain chromosomal regions or that it requires other protein partners. In contrast to the wild-type HA-PHF8, analogous studies revealed that the clinically observed F279S variant did not show clear nuclear localization, with apparent cytoplasmic localization. We conclude that the single-site mutation F279S abolishes PHF8 activity, thus linking the pathology of PHF8 mutations causing XLMR with cleft lip/palate to its function as a histone demethylase.
DISCUSSION
In summary, our results reveal that the catalytic domain of PHF8 is a 2OG oxygenase with selectivity for H3K9me2/ me1, H3K27me2 and H3K36me2 residues. We provide evidence that the pathology of PHF8 mutations causing XLMR with cleft lip/palate is linked to its function as a histone demethylase; efforts can now be directed towards determining how lysine methylation status is linked to the pathophysiology of Siderius XLMR syndrome. Given that the 2OG oxygenases have an absolute requirement for oxygen (6, 23) and that the HIFa hydroxylases, including FIH, act as sensors in the physiological response to hypoxia (20) , it is notable that maternal hypoxia has been linked to increased incidence of cleft lip/ palate not only in mice (5), but also in the acardiac human fetus (24) . In the human fetus, hypoxia is also proposed to arise as a result of maternal hypertension treatment (25) and maternal smoking (26) . The molecular mechanism of how oxygen and histone modifying enzymes such as PHF8 regulate the development and fusion of facial prominences can now be addressed; it is possible that it involves chromatin regulated gene expression including of homeobox genes, which are commonly associated with congenital abnormalities (27) .
Finally, because of their role in epigenetics and oncology, histone modifying enzymes are being extensively investigated, both in academia and industry, with histone deacetylase inhibitors already in clinical use (we note that some histone deacetylase inhibitors also inhibit demethylases) (28) . Although PHF8 may have different roles in development compared with adult organisms, our work suggests that when targeting histone demethylases or deacetylases, caution should be used in studies on compounds that inhibit PHF8 activity.
MATERIALS AND METHODS
Expression plasmids and protein purification
For expression in Escherichia coli, human PHF8 was cloned into the pNIC28-Bsa4 expression vector (residues 79 -447 and 1 -447) with an N-terminal His 6 -thioredoxin tag. For mammalian expression, full-length human PHF8 was cloned into the pEF6 vector with an N-terminal HA tag. Recombinant JMJD2A was prepared as reported (21) . All point mutations were generated using thermal cycling; for primer sequences see Supplementary Material, Table S1 . For large-scale expression, plasmids were transformed into E. coli BL21 cells, induced with 0.5 mM IPTG at OD 0.6 and grown for 4 h at 308C. Enzymes were purified by immobilized Ni(II) affinity chromatography and subsequent gel filtration chromatography.
Calf histone incubations
Bulk calf thymus type II-A histones (Sigma H9250) were incubated with purified PHF8 79 -447 in 20 mM Tris -HCl pH 8, 150 mM NaCl, 50 mM FeSO 4 . 7H 2 O, 1 mM 2OG and 2 mM ascorbate. Wild-type PHF8 (5 mg), PHF8 H247A (5 mg) or PHF8 F279S (5 -50 mg) were incubated with 25 mg histones in a total reaction volume of 100 ml. Reactions were performed at 378C for 4 -6 h before addition of Laemmli buffer, separation on 15% SDS-PAGE gels and western blot analysis. Rabbit anti-H3K9me1 (07 -450), -H3K9me2 (07 -441), -H3K9me3 (07 -442), -H3K4me1 (07 -436), -H3K27me1 (07 -447), -H3K27me2 (07 -452) and -H3K79me2 (05 -835) were from Millipore. Rabbit antiH3K36me1 (ab9048), -H3K36me3 (ab9050), -H3K4me2 (ab7766) and -Histone H3 (ab1791) were from AbCam. Rabbit anti-H3K36me2 (9758) was from Cell Signaling.
Immunofluorescence studies
HeLa cells were grown on coverslips in six-well plates, using DMEM supplemented with fetal bovine serum (10%) and penicillin/streptomycin. Cells were transfected with 1 -2 mg PHF8 1 -1024 , PHF8 1 -1024 
Structural modeling of PHF8 and FBXL11
The FBXL11 sequence was mapped by pair fitting onto the JMJD2A.H3K9me3 structure using PyMOL [PDB IDs: 2YU2, 2OQ6 (21, 22) ]. The high sequence similarity (61% identity) between the JmjC domains of PHF8 and FBXL11 (amino acids 234-334 and 199-299, respectively) was used to prepare a structure homology model for PHF8 based on an FBXL11 protein structure (PDB ID: 2YU2) (22) using the Phyre server (E-value: 6.95e217) (29) . The metal ion substituting for Fe(II) for crystallographic purposes was replaced by Fe(II) in Figure 1 and Supplementary Material, Fig. S3 .
Co-substrate turnover experiments
Recombinant enzymes and substrates were tested for their ability to stimulate PHF8-dependent decarboxylation of 1-[ 14 C]-labeled 2OG, as described for other 2OG oxygenases (30, 31) . Conversion of 2OG was calculated from the percentage of 1-[
14 C]-2OG that had been converted to 14 CO 2 gas; data were represented as pmol 2OG turnover per minute per micromolar of enzyme. Numbers shown are from one assay, performed in triplicates; error bars give the standard deviation.
Mass spectrometric analyses
Demethylation of peptides was analyzed using a MALDI-TOF microMX mass spectrometer in the positive ion reflectron mode. Assay conditions utilized similar 2OG turnover assay conditions except without the radioactive 2OG. Reactions were quenched with an equal volume of 0.1% formic acid/ MeOH at 48C. All samples for MS analyses were mixed with a-cyano-4-hydroxy-cinnamic acid as MALDI matrix (1:1) and spotted onto the target plate.
